ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pogrebniak, H. W.
Right arrow Articles by Pass, H. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pogrebniak, H. W.
Right arrow Articles by Pass, H. I.

The Annals of Thoracic Surgery, Vol 46, 20-23, Copyright © 1988 by The Society of Thoracic Surgeons


ARTICLES

Resection of pulmonary metastases from malignant melanoma: results of a 16-year experience

HW Pogrebniak, M Stovroff, JA Roth and HI Pass
Thoracic Oncology Section, National Cancer Institute, Bethesda, MD 20892.

Between 1970 and 1986, 49 patients had resection of presumed pulmonary metastases from malignant melanoma. Sixteen patients were found to have benign disease only despite the appearance of a new nodule in 13. Patients with benign disease had a significantly longer mean survival (169 months) compared with the group with malignant disease (22 months). Median survival for all patients with malignant disease was 13 months. Survival after resection did not correlate with the Clark level of the original lesion, lymph node status, disease-free interval, or number of nodules on preoperative tomograms. Two of 10 patients with 1 nodule resected are long-term survivors (88 and 120 months). Exploration in patients with presumed pulmonary metastases from melanoma is justified to rule out benign disease even if a new solitary nodule is detected. There are no prognostic indicators predicting survival after resection of melanoma metastases, and a significant number of patients will have benign disease.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
H. B. Neuman, A. Patel, C. Hanlon, J. D. Wolchok, A. N. Houghton, and D. G. Coit
Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival
Ann. Surg. Oncol., October 1, 2007; 14(10): 2847 - 2853.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
P. J. Allen and D. G. Coit
The Surgical Management of Metastatic Melanoma
Ann. Surg. Oncol., October 1, 2002; 9(8): 762 - 770.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Robert, V. Ambrogi, B. Mermillod, D. Dahabreh, and P. Goldstraw
Factors Influencing Long-Term Survival After Lung Metastasectomy
Ann. Thorac. Surg., March 1, 1997; 63(3): 777 - 784.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The Society of Thoracic Surgeons.